House lawmakers will once again be able to request certain health earmarks in the fiscal 2027 spending bill following a years-long ban ...
In today’s Pharma Pulse, the FDA unveils a Plausible Mechanism framework to fast-track ultra-rare disease therapies, while ...
Management's guidance language shifted from a general $4 billion revenue target by 2027 in Q3 to a more aggressive "double down" commitment to reaching the run rate by the end of 2026, not requiring ...
Dr. Garth Graham brings an unparalleled pedigree to the stage. In addition to his experience at Google and YouTube, Graham served as U.S. Deputy Assistant Secretary for Health under two ...
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Speaker submissions are officially open for NextGen 2026 as the practitioner-first conference seeks end-user leaders with implementation-driven case studies across logistics, retail, food & beverage, ...
Pharmacy leaders sound alarm on workforce crisis as shortages of pharmacists and technicians threaten health systems in 2026 and beyond.
The drugmaking unit of South Korea’s Lotte Group is betting on growth from a global shift in pharmaceutical production away from Chinese players amid rising geopolitical tension and tariff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results